Zhitong Finance App News, Jianmin Group (600976.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” approved and issued by the State Drug Administration, and the Claribolol ointment developed by the company was approved for listing. Indications: Used for topical topical treatment of patients with mild to moderate atopic dermatitis aged 3 months and above.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.